ZOCCHI, CHIARA
 Distribuzione geografica
Continente #
EU - Europa 857
NA - Nord America 816
AS - Asia 251
AF - Africa 5
Totale 1.929
Nazione #
US - Stati Uniti d'America 815
RU - Federazione Russa 422
PL - Polonia 126
IE - Irlanda 96
IT - Italia 87
SE - Svezia 73
SG - Singapore 71
HK - Hong Kong 60
CN - Cina 52
JO - Giordania 32
DE - Germania 22
IN - India 22
CH - Svizzera 13
KR - Corea 11
GB - Regno Unito 6
FI - Finlandia 5
CI - Costa d'Avorio 4
UA - Ucraina 3
NL - Olanda 2
VN - Vietnam 2
BE - Belgio 1
CA - Canada 1
ES - Italia 1
MU - Mauritius 1
TR - Turchia 1
Totale 1.929
Città #
Santa Clara 247
Warsaw 126
Dublin 96
Chandler 73
Singapore 64
Fairfield 54
Hong Kong 44
Ashburn 38
Seattle 25
Altamura 24
Florence 24
Lawrence 24
Houston 19
Moscow 19
Cambridge 18
Mumbai 18
Princeton 18
Wilmington 18
Woodbridge 18
Buffalo 17
Munich 17
New York 16
Beijing 14
Bern 13
Boston 13
Shanghai 13
San Diego 11
Seoul 11
Ann Arbor 7
Medford 7
Hillsboro 6
Kent 5
Los Angeles 5
Abidjan 4
West Jordan 4
Yubileyny 4
Boardman 3
Guangzhou 3
Helsinki 3
Redwood City 3
Andover 2
Campi Bisenzio 2
Cesano Boscone 2
Effeltrich 2
Jinan 2
Kilburn 2
Livorno 2
Lodi 2
Lusciano 2
Norwalk 2
Pune 2
Reggio Emilia 2
Trinitapoli 2
Tukwila 2
Vellore 2
Arezzo 1
Breendonk 1
Falls Church 1
Grosseto 1
Hagen 1
Hangzhou 1
Hoofddorp 1
Lappeenranta 1
Leawood 1
Lecce 1
London 1
Milan 1
Monmouth Junction 1
Nanjing 1
Naples 1
Pisa 1
Pontedera 1
Prato 1
Redmond 1
Salerno 1
Southwark 1
Staranzano 1
Toronto 1
Turin 1
Viagrande 1
Washington 1
Xingtai 1
Totale 1.203
Nome #
Clinical events beyond one year after an acute coronary syndrome: Insights from the RECLOSE 2-ACS study 252
Risk stratification using the CHA2DS2-VASc score in Takotsubo syndrome: Data from the Takotsubo Italian network 111
Emerging Medical Treatment for Hypertrophic Cardiomyopathy 87
Strength of clinical indication and therapeutic impact of the implantable cardioverter defibrillator in patients with hypertrophic cardiomyopathy 87
Relation between post-myocardial infarct remodelling and gelatinase activity in patients enrolled in the TIPTOP trial 85
Cellular determinants of arrhythmic rysk in hypertrophic cardiomyopathy 85
Decrease and Delay in Hospitalization for Acute Coronary Syndromes During the 2020 SARS-CoV-2 Pandemic 84
Predicting Mortality Risk in Older Hospitalized Persons With COVID-19: A Comparison of the COVID-19 Mortality Risk Score with Frailty and Disability 80
Prevalence of Inherited Cardiac Diseases Among Young Patients Requiring Permanent Pacing 78
Changes in the perceived epidemiology of amyloidosis: 20 year-experience from a Tertiary Referral Centre in Tuscany 77
Factors associated with persistence of symptoms 1 year after COVID-19: A longitudinal, prospective phone-based interview follow-up cohort study 75
Discriminatory ability of CHA2DS2-VASc score to predict residual platelet reactivity and outcomes in patients with acute coronary syndrome 73
Impact of mitraclip intervention on left ventricular remodelling and clinical outcome: data from Florence registry 72
Incidence of light chain amyloidosis in Florence metropolitan area, Italy: a population-based study 69
Early Diagnosis and Outcome in Patients With Wild-Type Transthyretin Cardiac Amyloidosis 67
Relationship between hyponatremia at hospital admission and cardiopulmonary profile at follow-up in patients with SARS-CoV-2 (COVID-19) infection 66
Prevalence and prognostic role of nonsustained ventricular tachycardia in cardiac amyloidosis 59
Clinical course and outcome of pregnancy in patients with hypertrophic cardiomyopathy 57
Incidence of stroke in patients with hypertrophic cardiomyopathy in stable sinus rhythm during long-term monitoring 53
Safety and efficacy of ranolazine in hypertrophic cardiomyopathy: Real-world experience in a National Referral Center 51
Sex-related differences in clinical presentation and all-cause mortality in patients with cardiac transthyretin amyloidosis and light chain amyloidosis 51
Prevalence and predictors of bradyarrhythmias requiring permanent pacing in patients with Anderson-Fabry disease 49
Myocardial infarction with non-obstructive coronary arteries in hypertrophic cardiomyopathy vs Fabry disease 47
Clinical scenarios of HCM-related mortality: Relevance of age and stage of disease at presentation 47
Clinical staging of Anderson-Fabry cardiomyopathy: An operative proposal 42
Impact of Pregnancy on the Natural History of Women with Hypertrophic Cardiomyopathy 37
Myocarditis and COVID-19 related issues 21
Totale 1.962
Categoria #
all - tutte 8.050
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.050


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202073 0 0 0 0 10 8 12 12 13 5 10 3
2020/202174 2 8 0 12 11 7 2 4 12 5 7 4
2021/2022141 10 2 7 1 2 7 0 13 19 9 28 43
2022/2023432 32 79 22 15 22 71 60 33 56 7 15 20
2023/2024249 6 24 26 12 17 36 15 56 6 19 23 9
2024/2025855 41 150 81 263 320 0 0 0 0 0 0 0
Totale 1.962